Fisher DA: Hyperthyroidism: Pediatric aspects , in Werner SC, Ingbar SH (eds): The Thyroid . New York, Harper & Row, 1978;, pp 805-813.
Saxena KM, Crawford JD, Talbot NB: Childhood thyrotoxicosis: A longer-term prospective . Br Med J 1964;;2:1153-1158.
Barnes HV, Blizzard RM: Antithyroid drug therapy for toxic diffuse goiter (Graves' disease): Thirty years experience in children and adolescents . J Pediatr 1977;;91:313-320.
Collen RJ, Landaw MD, Kaplan SA, et al: Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs . Pediatrics 1980;;65:550-556.
Smith BR, Hall R: Thyroid-stimulating immunoglobulins in Graves' disease . Lancet 1974;;2: 427-430.
Mukhtar ED, Smith BR, Pyle GA, et al: Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs . Lancet 1975;;1: 713-715.
Rickards C, Buckland P, Smith BR, et al: The interaction of Graves' IgG with the thyrotrophin receptor . FEBS Lett 1978;;127:17-21.
Valente WA, Vitti P, Yavin Z, et al: Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease . Proc Nati Acad Sci USA 1982;;79:6680-6684.
Solomon DH: The nature of Graves' hyperthyroidism, pp 379-382 in Brown J (moderator): Autoimmune thyroid diseases—Graves' and Hashimoto's . Ann Intern Med 1978;;88:379-391.
Strakosch CR, Wenzel BE, Row VV, et al: Immunology of autoimmune thyroid diseases . N Engl J Med 1982;;307:1499-1507.
Davies TF, Yeo PPB, Evered DC, et al: Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease . Lancet 1977;;1:1181-1182.
McKenzie JM, Zakarija M, Sato A: Humoral immunity in Graves' disease . Clin Endocrinol Metabol 1978;;7:31-45.
Teng CS, Yeung RT: Changes in thyroidstimulating antibody activity in Graves' disease with antithyroid drug and its relationship to relapse: A prospective study . J Clin Endocrinol Metabol 1980;;50:144-147.
McGregor AM, Smith BR, Hall R, et al: Prediction of relapse in hyperthyroid Graves' disease . Lancet 1980;;1:1101-1103.
Schleusener H, Schernthaner G, Mayr WR, et al: HLA-DR3 and HLA-DR5 associated thyrotoxicosis: Two different types of toxic diffuse goiter . J Clin Endocrinol Metabol 1983;;56: 781-785.
Farid NR, Stone E, Johnston G: Graves' disease and HLA: Clinical and epidemiological associations . Clin Endocrinol 1980;;13:535-544.
Brown RS, Kertiles LP, Reichlin S: Partial purification and characterization of thyrotropin binding inhibitory immunoglobulins from normal human plasma . J Clin Endocrinol Metabol 1983;; 56:156-163.
Kleinmann RE, Braverman LE, Vagenakis AG, et al: A new method for measurement of human thyroid-stimulating immunoglobulins . J Lab Clin Med 1980;;95:581-589.
Brown RS, Jackson IMD, Pohl SL, et al: Do thyroid-stimulating immunoglobulins cause nontoxic and toxic multinodular goitre? Lancet 1978;; 1:904-906.
Zakarija M, McKenzie JM, Banovac K: Clinical significance of thyroid-stimulating antibody in Graves' disease . Ann Intern Med 1980;;93: 28-32.
Valente WA, Vitti P, Rotella CM, et al: Antibodies that promote thyroid growth: A distinct population of thyroid-stimulating autoantibodies . N Engl J Med 1983;;309:1028-1034.
Drexhage HA, Botazzo GF, Doniach D, et al: Evidence for thyroid growth-stimulating immunoglobulins in some goitrous thyroid diseases . Lancet 1980;;2:287-292.
Sugenoya A, Kidd A, Row VV: Correlation between thyrotropin-displacing activity and human thyroid-stimulatory activity by immunoglobulins from patients with Graves' disease and other thyroid disorders . J Clin Endocrinol Metabol 1979;;48:398-402.
Kuzuya N, Chiu SC, Ikeda H, et al: Correlation between thyroid stimulators and 3,5,3'iodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: Comparison of assays by thyroid-stimulating and thyrotropin-displacing activities . J Clin Endocrinol Metabol 1979;;48:706-711.
Toft AD, Irvine WJ, Seth J, et al: Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis . Lancet 1975;;2:576-578.
Buerklin EM, Schimmel M, Utiger RD: Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs . J Clin Endocrinol Metabol 1976;;43:419-427.
Orgiazzi J, Williams DE, Chopra IJ, et al: Human thyroid adenyl cyclase–stimulating activity in immunoglobulin G of patients with Graves' disease . J Clin Endocrinol Metabol 1976;;42: 341-354.
Shewring G, Smith BR: An improved radioreceptor assay for TSH receptor antibodies . Clin Endocrinol 1982;;17:409-417.
Southgate K, Creagh F, Teece M, et al: A receptor assay for the measurement of TSH receptor antibodies in unextracted serum . Clin Endocrinol 1984;;20:539-543.